Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update

SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will report financial results and provide a corporate update for the second quarter ended June 30, 2023. The company’s management will host a webcast and…Read More

Leave a Reply

Your email address will not be published. Required fields are marked *